Add this topic to your myFT Digest for news straight to your inbox
You select the topic, we deliver the news.
Makers of medicines with $22bn sales a year expected to fight hard to delay rivals’ introduction
Retirement of founder Vasella poses questions for future strategy
Swiss drugs group’s chairman should not have accepted $78m payment
Claire Adler considers a trend toward cultural crossovers
The same global insight. Faster than ever before on all your devices.